Antibodies have been widely used in research and diagnosis, yet one of the most important specifications of antibodies, the specificity, has not been effectively addressed due to the lack of effective tools. OriGene offers a solution to this problem. This presentation will showcase OriGene's novel tool and introduce UltraMAB, a new class of monoclonal antibodies with validated specificity.